Our results confirm that, in response to cocktail cytokines, ILC2 upregulated CD86 and PD-L1, as observed in ILC2 from IL-33-treated mice and humans (38) in infectious diseases (39), leading to an increase in the effector response (40). The gene discussed is IL33; the disease is infectious disease.